AVONEX® Combination Trial - "ACT"

Clinical trial NCT00112034 · COMPLETED

Trial details

NCT number: NCT00112034
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2003-06-01
Primary completion: 2006-06-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.